“…In one series, the diagnostic rate in the same uteri varied between 31% and 62%, depending on the number of samples obtained (21). Although adenomyosis is seen in both symptomatic patients and asymptomatic patients, it appears to be more common in symptomatic patients (3,22). The variable appearance of adenomyosis at US relates to the distribution of the heterotopic endometrial tissue, the presence and degree of associated muscle hypertrophy, and the presence and size of the cysts within the heterotopic endometrial tissue.…”
The presence of subendometrial linear striations, subendometrial echogenic nodules, or asymmetric myometrial thickness improves the specificity and PPV of US in diagnosing adenomyosis.
“…In one series, the diagnostic rate in the same uteri varied between 31% and 62%, depending on the number of samples obtained (21). Although adenomyosis is seen in both symptomatic patients and asymptomatic patients, it appears to be more common in symptomatic patients (3,22). The variable appearance of adenomyosis at US relates to the distribution of the heterotopic endometrial tissue, the presence and degree of associated muscle hypertrophy, and the presence and size of the cysts within the heterotopic endometrial tissue.…”
The presence of subendometrial linear striations, subendometrial echogenic nodules, or asymmetric myometrial thickness improves the specificity and PPV of US in diagnosing adenomyosis.
“…The observations that the local release of levonorgestrel in the uterine cavity can cause regression of adenomyosis is further evidence that these lesions can respond to high intrauterine doses of progestins by reducing proliferation and augmenting apoptosis in a similar way to that occurring in the eutopic endometrium [6,14,15]. This is in agreement with our findings that the presence of Mirena in the uterine cavity decreases proliferation and bcl-2 expression in adenomyosis more efficiently than oral contraceptive pills, which were able effectively to reduce proliferation but not bcl-2 expression.…”
During the luteal phase, both ki-67 and bcl-2 expression is reduced in adenomyotic lesions in a similar way to that occurring in patients using Mirena. Oral contraceptives, on the other hand, do not affect bcl-2 expression in adenomyosis.
“…Optische Veränderungen des Endometriums (Endometriuminvaginationen, Trabekulationen, Regionen einer Neovaskularisation) weisen auf eine Adenomyosis hin. Durch Gewinnung eines histologisch zu untersuchenden Präparates wird die Diagnose gesichert [29]. Die Entnahme einer Endometriumbiopsie mit der elektrischen Schlinge des Resektoskops ist eine Mög-lichkeit.…”
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.